# Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel

> **NCT01222312** · PHASE2 · COMPLETED · sponsor: **Krankenhaus Nordwest** · enrollment: 88 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Oxaliplatin
- **DRUG:** Docetaxel
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT01222312
- **Lead sponsor:** Krankenhaus Nordwest
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2011-10
- **Final completion:** 2011-11
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2011-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01222312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01222312, "Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01222312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*